mMCQ.

Navigation Menu

Step into mMCQ.

Launch mMCQ. diagnostic

Explore mMCQ.

MDCAT prepFree DiagnosticPricing & SubscribeSign in

Resources

Terms & Conditions

mMCQ.

© 2021 - 2025 mMCQ.All rights reserved.

WhatsApp
O Levels Biology (5090)•5090/11/M/J/22
Question 40 from 5090/11/M/J/22

Explanation

Cost advantage of recombinant insulin

Steps:

  • Recombinant DNA technology inserts human insulin genes into bacteria for mass production.
  • Bacteria culture yields large quantities of insulin efficiently without animal sourcing.
  • Animal insulin extraction involves costly harvesting and purification from pancreases.
  • This makes bacterial insulin cheaper overall for patients.

Why D is correct:

  • Recombinant production scales via bacterial replication, reducing costs per unit compared to labor-intensive animal extraction.

Why the others are wrong:

  • A: Insulin treats existing diabetes but does not prevent its development.
  • B: Insulin replacement therapy does not regenerate pancreatic cells.
  • C: Human insulin causes fewer allergic reactions and side effects than animal-derived versions.

Final answer: D

Topic: Genetic modification

Practice more O Levels Biology (5090) questions on mMCQ.me